Bovolenta Tânia M, de Azevedo Silva Sônia Maria Cesar, Arb Saba Roberta, Borges Vanderci, Ferraz Henrique Ballalai, Felicio Andre C
Programa de Pós-Graduação, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Movement Disorders Department in Neurology, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Parkinsons Dis. 2017;2017:3410946. doi: 10.1155/2017/3410946. Epub 2017 Mar 5.
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease worldwide, affecting more than four million people. Typically, it affects individuals above 45, when they are still productive, compromising both aging and quality of life. Therefore, the cost of the disease must be identified, so that the use of resources can be rational and efficient. Additionally, in Brazil, there is a lack of research on the costs of neurodegenerative diseases, such as PD, a gap addressed in this study. This systematic review critically addresses the various methodologies used in original research around the world in the last decade on the subject, showing that costs are hardly comparable. Nonetheless, the economic and social impacts are implicit, and important information for public health agents is provided.
帕金森病（PD）是全球第二大常见的神经退行性疾病，影响着超过400万人。通常，它影响45岁以上仍处于工作年龄段的人群，对老龄化和生活质量都造成损害。因此，必须确定该疾病的成本，以便合理有效地利用资源。此外，在巴西，缺乏对神经退行性疾病（如帕金森病）成本的研究，本研究填补了这一空白。本系统综述批判性地探讨了过去十年全球范围内关于该主题的原始研究中使用的各种方法，表明成本很难进行比较。尽管如此，经济和社会影响是不言而喻的，并且为公共卫生工作者提供了重要信息。
